CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (CTD) AS INITIAL THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

被引:0
|
作者
Vasquez, J. [1 ]
Ruiz, R. [1 ]
Aliaga, K. [1 ]
Valencia, F. [1 ]
Enriquez, D. [1 ]
Palacios, V. [2 ]
Quintana, S. [1 ]
Casanova, L. [3 ]
机构
[1] Inst Nacl Enfermedades Neoplas, Med Oncol, Lima, Peru
[2] Hosp Cayetano Heredia, Med Oncol, Lima, Peru
[3] Inst Oncol Miraflores, Med Oncol, Lima, Peru
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1991
引用
收藏
页码:798 / 798
页数:1
相关论文
共 50 条
  • [1] Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients.
    Chavez, Jule Franve Vasquez
    Mendoza, Rossana Esther Ruiz
    Llerena, Karina Mayra Aliaga
    Valencia, Fernando
    Enriquez, Daniel
    Palacios, Victor
    Casanova, Luis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Russell, Nigel H.
    Bell, Sue E.
    Szubert, Alexander J.
    Coy, Nuria Navarro
    Cook, Gordon
    Feyler, Sylvia
    Byrne, Jenny L.
    Roddie, Huw
    Rudin, Claudius
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Jackson, Graham H.
    Child, J. Anthony
    [J]. BLOOD, 2011, 118 (05) : 1231 - 1238
  • [3] Influence of Stem Cell Mobilization After Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Regimen in Patients with Newly Diagnosed Multiple Myeloma
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Jung, Sung-Hoon
    Bae, Soo-Young
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. BLOOD, 2011, 118 (21) : 840 - 840
  • [4] Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen
    Jung, Sung-Hoon
    Park, Hyungchul
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Mi-Young
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (01) : 92 - 97
  • [5] Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen
    Sung-Hoon Jung
    Hyungchul Park
    Jae-Sook Ahn
    Deok-Hwan Yang
    Mi-Young Kim
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    [J]. International Journal of Hematology, 2013, 97 : 92 - 97
  • [6] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
  • [7] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
  • [8] Efficacy and safety of thalidomide and dexamethasone combination with or without cyclophosphamide in patients with newly diagnosed multiple myeloma
    Kim, Y.-K.
    Lee, J. J.
    Sohn, S. K.
    Shin, H. J.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Kim, D. H.
    Yang, D. H.
    Cho, S. H.
    Chung, I. J.
    Kim, H. J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 411 - 412
  • [9] Superiority of Triple Combination Bortezomib plus Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide plus Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients
    Crusoe, Edvan De Queiroz
    Higashi, Fabiana
    Martinez, Gracia
    Bittencourt, Rosane
    Maiolino, Angelo
    Sousa, Lais
    Nunes, Renata Ferreira Marques
    Ribeiro, Glaciano
    Nicacio, Jandir
    Zanella, Karla Richter
    Magalhaes, Andre
    Leao, Danielle
    Pinto Neto, Jorge Vaz
    Hallack Neto, Abrahao Elias
    Braga, Walter
    Souza, Emmanuella G.
    Guimaraes, Antonio Julio A. M.
    Durigon, Giovanna Steffenello
    Laks, Dani
    Kutner, Jose Mauro
    Colli, Gilberto
    Santucci, Rodrigo
    Magalhaes, Roberto Jose Pessoa
    Hungria, Vania T. M.
    [J]. BLOOD, 2017, 130
  • [10] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    [J]. BLOOD, 2009, 114 (22) : 1494 - 1495